Articles from R1 RCM Inc.

R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO

Stockholders to Receive $14.30 Per Share in Cash

Sets Final Bid Deadline of July 31, 2024

MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQRCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024. The Company issued the following statement:

Report details company’s continued commitment to corporate responsibility and sustainability on behalf of its customers and their patients, employees, communities, and shareholders

Top rankings in Ambulatory RCM Services, Robotic Process Automation and Denials Management Services underscore expertise and ability to deliver complete range of flexible healthcare revenue cycle solutions

Independent reports highlight today’s top challenges and best practices during challenging financial times